TGF-β and IL-6 family signalling crosstalk: an integrated model

References

• Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. 2006. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 8:1195–1203.
   PubMed Web of Science ®Google Scholar
• Aoki H, Ohnishi H, Hama K, Shinozaki S, Kita H, Yamamoto H, Osawa H, et al. 2006. Existence of autocrine loop between interleukin-6 and transforming growth factor-β1 in activated rat pancreatic stellate cells. J Cell Biochem 99:221–228.
   PubMed Web of Science ®Google Scholar
• Ashall L, Horton CA, Nelson DE, Paszek P, Harper CV, Sillitoe K, Ryan S. 2009. Pulsatile stimulation determines timing and specificity of nf-κb-dependent transcription. Science 324:242–246.
   PubMed Web of Science ®Google Scholar
• Babon J, Kershaw N, Murphy J, Liau N, Nicola N. 2014. S-3: Inhibition of IL-6 family cytokines by SOCS3: Characterizing the mode of inhibition and the basis of its specificity. Cytokine 70:21.
   Web of Science ®Google Scholar
• Bajzer Ž, Strehler EE. 2012. About and beyond the henri-michaelisines by SOCS3: Characterizing the mode of inhibition and t. Biochem Biophys Res Commun 417:982–985.
   PubMedGoogle Scholar
• Blüthgen N. 2015. Signaling output: It’s all about timing and feedbacks. Mol Syst Biol 11:843.
   PubMed Web of Science ®Google Scholar
• Bluyssen HA, Rastmanesh MM, Tilburgs C, Jie K, Wesseling S, Goumans M-J, Boer P, et al. 2010. Ifn γ-dependent socs3 expression inhibits il-6-induced stat3 phosphorylation and differentially affects il-6 mediated transcriptional responses in endothelial cells. Am J Physiol: Cell Physiol 299:C354–C362.
   PubMed Web of Science ®Google Scholar
• Bode JG, Albrecht U, Häussinger D, Heinrich PC, Schaper F. 2012. Hepatic acute phase proteins/10.1152/ajpcell.00513.200910.1152/ytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. Eur J Cell Biol 91:496–505.
   PubMed Web of Science ®Google Scholar
• Boulanger MJ, Chow D-C, Brevnova EE, Garcia KC. 2003. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 300:2101–2104.
   PubMed Web of Science ®Google Scholar
• Bromberg J, Wang TC. 2009. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15:79–80.
   PubMed Web of Science ®Google Scholar
• Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, et al. 2012. Dependency of colorectal cancer on a tgf-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22:571–584.
   PubMed Web of Science ®Google Scholar
• Chang S-C, Lin P-C, Lin J-K, Lin C-H, Yang S-H, Liang W-Y, Chen W-S, Jiang J-K. 2016. Mutation spectra of common cancer-associated genes in different phenotypes of colorectal carcinoma without distant metastasis. Ann Surg Oncol 23:849–855.
   PubMed Web of Science ®Google Scholar
• Chung SS, Wu Y, Okobi Q, Adekoya D, Atefi M, Clarke O, Dutta P, Vadgama JV. 2017. Proinflammatory cytokines il-6 and tnf-α increased telomerase activity through nf-κb/stat1/stat3 activation, and withaferin a inhibited the signaling in colorectal cancer cells. Mediators Inflamm 2017;2017:5958429.
   PubMedGoogle Scholar
• Chung S-W, Miles FL, Sikes RA, Cooper CR, Farach-Carson MC, Ogunnaike BA. 2009. Quantitative modeling and analysis of the transforming growth factor beta signaling pathway. Biophys J 96:1733–1750.
   PubMed Web of Science ®Google Scholar
• Clarke DC, Brown ML, Erickson RA, Shi Y, Liu X. 2009. Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics. Mol Cell Biol 29:2443–2455.
   PubMed Web of Science ®Google Scholar
• Coorey NJ, Shen W, Zhu L, Gillies MC. 2015. Differential expression of IL-6/gp130 cytokines, Jak-STAT signaling and neuroprotection after Müller cell ablation in a transgenic mouse model role of Müller cells in IL-6/gp130 and Jak-STAT activity. Invest Ophthalmol Vis Sci 56:2151–2161.
   PubMed Web of Science ®Google Scholar
• Coskun M, Olsen AK, Bzorek M, Holck S, Engel UH, Nielsen OH, Troelsen JT. 2014. Involvement of CDX2 in the crosstalk between TNF-α and Wnt signaling pathway in the colon cancer cell line Caco-2. Carcinogenesis 35(5):1185.
   PubMed Web of Science ®Google Scholar
• Darnell JE, Kerr IM, Stark GR. 1994. Jak-stat pathways and transcriptional activation in response to ifns and other extracellular signaling proteins. Science 264:1415–1421.
   PubMed Web of Science ®Google Scholar
• Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276:12477–12480.
   PubMed Web of Science ®Google Scholar
• Eichhorn PJ, Rodón L, Gonzàlez-Juncà A, Dirac A, Gili M, Martínez-Sáez E, Aura C, et al. 2012. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med 18:429–435.
   PubMed Web of Science ®Google Scholar
• Ellermeier J, Wei J, Duewell P, Hoves S, Stieg MR, Adunka T, Noerenberg D, et al. 2013. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. Cancer Res 73:1709–1720.
   PubMed Web of Science ®Google Scholar
• Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, et al. 2008. STAT3 and STAT1 mediate IL-11teknMay-54 and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118(5):1727.
   PubMed Web of Science ®Google Scholar
• Fall CP. 2002. Computational cell biology (Interdisciplinary Applied Mathematics, Vol. 20. New York: Springer-Verlag. ISBN:0387953698.
   Google Scholar
• Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759–767.
   PubMed Web of Science ®Google Scholar
• Feng X-H, Derynck R. 2005. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21:659–693.
   PubMed Web of Science ®Google Scholar
• Ferguson SS. 2001. Evolving concepts in g protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 53(1):1–24.
   PubMed Web of Science ®Google Scholar
• Funahashi A, Matsuoka Y, Jouraku A, Kitano H, Kikuchi N. 2006. CellDesigner: A modeling tool for biochemical networks. In Proceedings of the 38th conference on Winter simulation. Winter Simulation Conference; p 1707–707se.
   Google Scholar
• Gabay C. 2006. Interleukin-6 and chronic inflammation. Arthritis Res Ther 8:2.S3.
   PubMed Web of Science ®Google Scholar
• Garbers C, Aparicio-Siegmund S, Rose-John S. 2015. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition. Curr Opin Immunol 34:75–82.
   PubMed Web of Science ®Google Scholar
• Gilbert RW, Vickaryous MK, Viloria-Petit AM. 2016. Signalling by transforming growth factor beta isoforms in wound healing and tissue regeneration. J Dev Biol 4:21.
   PubMed Web of Science ®Google Scholar
• Gong Z, Aldeen M, Elsner L. 2002. A note on a generalized cramer0.3390/. Linear Algebra Appl 340:253–254.
   Google Scholar
• Goodman OB, Krupnick JG, Penn RB, Gagnon AW, Keen JH, Benovic JL. 1997. G-protein-coupled receptor endocytosis. Catecholamines: Bridging Basic Science with Clinical Medicine: Bridging Basic Science with Clinical Medicine, 42:429.
   Google Scholar
• Grönroos E, Hellman U, Heldin C-H, Ericsson J. 2002. Control of smad7 stability by competition between acetylation and ubiquitination. Mol Cell 10:483–493.
   PubMed Web of Science ®Google Scholar
• Guo X, Wang X-F. 2009. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19:71–88.
   PubMed Web of Science ®Google Scholar
• Haddad JJ. 2015. The irreversible inhibition of the mapk p38 pathway downregulates lps-augmented release of interleukin-related inflammatory cytokines (il-1β, il-6): Immune surveillance unraveling iκb-α/nf-κb phosphorylation state-independent mechanism in vitro. Am J Med Biol Res 3(5):133–138.
   Google Scholar
• Han J, Kamber M, Pei J. 2011. Data mining: Concepts and techniques. New York: Elsevier.
   Google Scholar
• Heinrich P, Behrmann I, Haan S, Hermanns H, Muller-Newen G, Schaper F. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1–20.
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway1. Biochem J 334:297–314.
   PubMed Web of Science ®Google Scholar
• Heldin C-H, Moustakas A. 2012. Role of Smads in TGFβ signaling. Cell Tissue Res 347:21–36.
   PubMed Web of Science ®Google Scholar
• Hirano T, Nakajima K, Hibi M. 1997. Signaling mechanisms through gp130: A model of the cytokine system. Cytokine Growth Factor Rev 8:241–252.
   PubMedGoogle Scholar
• Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S-I, et al. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76.
   PubMed Web of Science ®Google Scholar
• Hsu M-P, Frausto R, Rose-John S, Campbell IL. 2015. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M. Glia 63:132–141.
   PubMed Web of Science ®Google Scholar
• Huang Y, Bharill S, Karandur D, Peterson SM, Marita M, Shi X, Kaliszewski MJ, et al. 2016. Molecular basis for multimerization in the activation of the epidermal growth factor receptor. eLife 5:e14107.
   PubMed Web of Science ®Google Scholar
• Huang ZJ, Chu Y, Hahn J. 2010. Model simplification procedure for signal transduction pathway models: An application to IL-6 signaling. Chem Eng Sci 65:1964–1975.
   Web of Science ®Google Scholar
• Ishihara K, Hirano T. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13:357–368.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Maeda T, Hikita H, Miyatake K. 1988. The computerized derivation of rate equations for enzyme reactions on the basis of the pseudo-steady-state assumption and the rapid-equilibrium assumption. Biochem J 251:175–181.
   PubMed Web of Science ®Google Scholar
• Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, et al. 2005. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat Med 11:845–852.
   PubMed Web of Science ®Google Scholar
• Jullien J, Guili V, Reichardt LF, Rudkin BB. 2002. Molecular kinetics of nerve growth factor receptor trafficking and activation. J Biol Chem 277:38700–38708.
   PubMed Web of Science ®Google Scholar
• Kamimura D, Ishihara K, Hirano T. 2004. IL-6 signal transduction and its physiological roles: The signal orchestration model, pages 1–38. Berlin, Heidelberg: Springer. ISBN:9783540202134. Book title: Reviews of physiology, biochemistry and pharmacology.
   Google Scholar
• Kao S-C, Jaiswal RK, Kolch W, Landreth GE. 2001. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 276:18169–18177.
   PubMed Web of Science ®Google Scholar
• Kasprzycka M, Marzec M, Liu X, Zhang Q, Wasik MA. 2006. Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3. Proc Natl Acad Sci 103:9964–9969.
   PubMed Web of Science ®Google Scholar
• Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell 6:1365–1375.
   PubMed Web of Science ®Google Scholar
• Kenney JF, Keeping ES. 1951. Mathematics of statistics-part two. pages 130essti
   Google Scholar
• Khatibi S, Zhu H-J, Wagner J, Tan CW, Manton JH, Burgess AW. 2017. Mathematical model of tgf-β signalling: Feedback coupling is consistent with signal switching. BMC Syst Biol 11:48.
   PubMed Web of Science ®Google Scholar
• Khatibi S. 2016. Signalling and crosstalk in cytokine pathways: Mathematical modelling and quantitative analysis [dissertation]. Melbourne: University of Melbourne, Electrical and Electronic Engineering (Chapter 4).
   Google Scholar
• Kim DJ, Tremblay ML, DiGiovanni J. 2010. Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation. PLoS One 5:e10290.
   PubMed Web of Science ®Google Scholar
• Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, Takaki H, et al. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor>β1. J Exp Med 203:1021–1031.
   PubMed Web of Science ®Google Scholar
• Klipp E, Liebermeister W. 2006. Mathematical modeling of intracellular signaling pathways. BMC Neurosci 7:S10.
   PubMed Web of Science ®Google Scholar
• Koldsø H, Sansom MS. 2013. Signal transduction by a cytokine receptor: Multi-scale computational studies of the membrane associated Gp130 receptor complex. Biophys J 104:608a.
   Web of Science ®Google Scholar
• Kouhara H, Hadari Y, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J. 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89:693–702.
   PubMed Web of Science ®Google Scholar
• Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S-I, Isshiki K, Isono M, et al. 2007. Sirt1 inhibits transforming growth factor β-induced apoptosis in glomerular mesangial cells via smad7 deacetylation. J Biol Chem 282:151–158.
   PubMed Web of Science ®Google Scholar
• Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Inoue K, Nagayasu T, Sekine I. 2006. Activation of stat3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep 15(6):1445.
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Avruch J. 2012. Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev 92:689–737.
   PubMed Web of Science ®Google Scholar
• Li R, Chung AC, Dong Y, Yang W, Zhong X, Lan HY. 2013. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway. Kidney Int 84:1129–1144.
   PubMed Web of Science ®Google Scholar
• Lillemeier BF, Köster M, Kerr IM. 2001. Stat1 from the cell membrane to the DNA. EMBO J 20:2508–2517.
   PubMed Web of Science ®Google Scholar
• Liton PB, Li G, Luna C, Gonzalez P, Epstein DL. 2009. Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. Mol Vis 15:326.
   PubMed Web of Science ®Google Scholar
• Liu L, Santora R, Rao JN, Guo X, Zou T, Zhang HM, Turner DJ, Wang J-Y. 2003. Activation of TGF-β-Smad signaling pathway following polyamine depletion in intestinal epithelial cells. Am J Physiol: Gastrointest Liver Physiol 285:G1056–G1067.
   PubMed Web of Science ®Google Scholar
• Luwor RB, Baradaran B, Taylor L, Iaria J, Nheu T, Amiry N, Hovens CM, et al. 2012. Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo. Oncogene 32:2433–2441.
   PubMed Web of Science ®Google Scholar
• Massague J. 1990. The transforming growth factor-beta family. Annu Rev Cell Biol 6:597–641.
   PubMedGoogle Scholar
• McAdams HH, Arkin A. 1998. Simulation of prokaryotic genetic circuits. Annu Rev Biophys Biomol Struct 27:199–224.
   PubMedGoogle Scholar
• Melke P, Jnsson H, Pardali E, ten Dijke P, Peterson C. 2006. A rate equation approach to elucidate the kinetics and robustness of the TGF-β pathway. Biophys J 91:4368–4380.
   PubMed Web of Science ®Google Scholar
• Mishra S, Sun L. 2012. Role of TGF-β superfamily ligand and mechanism of osteoblastic tumorigenesis of prostate cancer cells. Cancer Res 72:5317–5317.
   PubMed Web of Science ®Google Scholar
• Miyake T, Alli NS, McDermott JC. 2010. Nuclear function of smad7 promotes myogenesis. Mol Cell Biol 30:722–735.
   PubMed Web of Science ®Google Scholar
• Moraga I, Wernig G, Wilmes S, Gryshkova V, Richter CP, Hong W-J, Sinha R, et al. 2015. Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands. Cell 160:1196–1208.
   PubMed Web of Science ®Google Scholar
• Moya C, Huang Z, Cheng P, Jayaraman A, Hahn J. 2011. Investigation of il-6 and il-10 signalling via mathematical modelling. Syst Biol, IET 5:15–26.
   PubMed Web of Science ®Google Scholar
• Nagahashi M, Wakai T, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T, Sakata J, et al. 2016. Genomic landscape of colorectal cancer in Japan: Clinical implications of comprehensive genomic sequencing for precision medicine. Genome Med 8:136.
   PubMed Web of Science ®Google Scholar
• Papin JA, Palsson BO. 2004. The jak-stat signaling network in the human b-cell: An extreme signaling pathway analysis. Biophys J 87:37–46.
   PubMed Web of Science ®Google Scholar
• Pertovaara M, Silvennoinen O, Isomäki P. 2016. Cytokine-induced stat1 activation is increased in patients with primary Sjögren’s syndrome. Clin Immunol 165:60–67.
   PubMed Web of Science ®Google Scholar
• Pickup M, Novitskiy S, Moses HL. 2013. The roles of TGF [beta] in the tumour microenvironment. Nat Rev Cancer 13:788–799.
   PubMed Web of Science ®Google Scholar
• Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, et al. 2014. Duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 106:djt369–djt369.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Ravi L, Kung H-J. 1998. Requirement of erbb2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393:83–85.
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. 2014. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921.
   PubMed Web of Science ®Google Scholar
• Rao JN, Li L, Bass BL, Wang J-Y. 2000. Expression of the TGF-14-015510.1158/0008-5472.CAN-14-015510.1158/0008-5472.CAN-14-0155"snamne depletion. Am J Physiol: Cell Physiol 279:C1034.
   PubMedGoogle Scholar
• Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, et al. 2009. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457:200–204.
   PubMed Web of Science ®Google Scholar
• Rivett AJ. 1985. Regulation of intracellular protein turnover: Covalent modification as a mechanism of marking proteins for degradation. Curr Top Cell Regul 28:291–337.
   Google Scholar
• Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, et al. 2014. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest 124:1853.
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, McMillan DC. 2016. Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/jak/stat signal transduction pathway in patients with cancer. Transl Res 167:61–66.
   PubMed Web of Science ®Google Scholar
• Ryu H, Chung M, Dobrzyński M, Fey D, Blum Y, Lee SS, Peter M, et al. 2015. Frequency modulation of erk activation dynamics rewires cell fate. Mol Syst Biol 11:838.
   PubMed Web of Science ®Google Scholar
• Sako Y, Ueda M. 2010. Cell signaling reactions: Single-molecular kinetic analysis. New York: Springer Science & Business Media. ISBN: 9789048198634 (Chapter 1).
   Google Scholar
• Sakon S, Xue X, Takekawa M, Sasazuki T, Okazaki T, Kojima Y, Piao J-H, et al. 2003. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22:3898–3909.
   PubMed Web of Science ®Google Scholar
• Schaper F, Rose-John S. 2015. Interleukin-6: Biology, signaling and strategies of blockade. Cytokine Growth Factor Rev 26:475–487.
   PubMed Web of Science ®Google Scholar
• Schindler C, Darnell Jr J. 1995. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem 64:621–652.
   PubMed Web of Science ®Google Scholar
• Schmierer B, Tournier AL, Bates PA, Hill CS. 2008. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci 105:6608–6613.
   PubMed Web of Science ®Google Scholar
• Seger R, Krebs EG. 1995. The mapk signaling cascade. FASEB J 9:726–735.
   PubMed Web of Science ®Google Scholar
• Simonsson M, Heldin C-H, Ericsson J, Grönroos E. 2005. The balance between acetylation and deacetylation controls smad7 stability. J Biol Chem 280:21797–21803.
   PubMed Web of Science ®Google Scholar
• Singh A, Jayaraman A, Hahn J. 2006. Modeling regulatory mechanisms in il-6 signal transduction in hepatocytes. Biotechnol Bioeng 95:850–862.
   PubMed Web of Science ®Google Scholar
• Skiniotis G, Boulanger MJ, Garcia KC, Walz T. 2005. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat Struct Mol Biol 12:545–551.
   PubMed Web of Science ®Google Scholar
• Skiniotis G, Lupardus PJ, Martick M, Walz T, Garcia KC. 2008. Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol Cell 31:737–748.
   PubMed Web of Science ®Google Scholar
• Son DJ, Hong JE, Ban JO, Park JH, Lee HL, Gu SM, Hwang JY, et al. 2015. Synergistic inhibitory effects of cetuximab and cisplatin on human colon cancer cell growth via inhibition of the ERK-dependent EGF receptor signaling pathway. BioMed Res Int 2015:397563–397563.
   PubMedGoogle Scholar
• Thiolloy S, Edwards JR, Fingleton B, Rifkin DB, Matrisian LM, Lynch CC. 2012. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. PLoS One 7:e29862.
   PubMed Web of Science ®Google Scholar
• Turner M, Chantry D, Feldmann M. 1990. Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 2:211–216.
   PubMedGoogle Scholar
• Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT. 2002. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 277:16879–16887.
   PubMed Web of Science ®Google Scholar
• Vilar JMG, Jansen R, Sander C. 2006. Signal processing in the TGF-beta superfamily ligand-receptor network. PLoS Comput Biol 2:e3.
   PubMed Web of Science ®Google Scholar
• Villarino AV, Kanno Y, Ferdinand JR, OShea JJ. 2015. Mechanisms of jak/stat signaling in immunity and disease. J Immunol 194:21–27.
   PubMed Web of Science ®Google Scholar
• Vizán P, Miller DSJ, Gori I, Das D, Schmierer B, Hill CS. 2013. Controlling long-term signaling: Receptor dynamics determine attenuation and refractory behavior of the tgf-mefnam. Sci Signal, 6:ra106gnalin.
   Web of Science ®Google Scholar
• Wang Y, van Boxel-Dezaire AH, Cheon H, Yang J, Stark GR. 2013. Stat3 activation in response to il-6 is prolonged by the binding of il-6 receptor to egf receptor. Proc Natl Acad Sci 110:16975–16980.
   PubMed Web of Science ®Google Scholar
• Wilks AF, Harpur AG. 1994. Cytokine signal transduction and the JAK family of protein tyrosine kinases. Bioessays 16:313–320.
   PubMed Web of Science ®Google Scholar
• Wormald S, Hilton DJ. 2007. The negative regulatory roles of suppressor of cytokine signaling proteins in myeloid signaling pathways. Curr Opin Hematol 14:9–15.
   PubMed Web of Science ®Google Scholar
• Wormald S, Zhang J-G, Krebs DL, Mielke LA, Silver J, Alexander WS, Speed TP, et al. 2006. The comparative roles of suppressor of cytokine signaling-1 and-3 in the inhibition and desensitization of cytokine signaling. J Biol Chem 281:11135–11143.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Sekine Y, Kashima K, Kubota A, Sato N, Aoki N, Matsuda T. 2002. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun 297:811–817.
   PubMed Web of Science ®Google Scholar
• Yan X, Chen Y-G. 2011. Smad7: Not only a regulator, but also a cross-talk mediator of tgf-β signalling. Biochem J 434:1–10.
   PubMed Web of Science ®Google Scholar
• Yanagisawa M, Nakashima K, Takizawa T, Ochiai W, Arakawa H, Taga T. 2001. Signaling crosstalk underlying synergistic induction of astrocyte differentiation by BMPs and IL-6 family of cytokines. FEBS Lett 489:139–143.
   PubMed Web of Science ®Google Scholar
• Yang C, Li C, Li M, Tong X, Hu X, Yang X, Yan X, et al. 2015. CYP2S1 depletion enhances colorectal cell proliferation is associated with PGE2-mediated activation of β-catenin signaling. Exp Cell Res 331:377–386.
   PubMed Web of Science ®Google Scholar
• Yu H, Pardoll D, Jove R. 2009. Stats in cancer inflammation and immunity: A leading role for stat3. Nat Rev Cancer 9:798–809.
   PubMed Web of Science ®Google Scholar
• Yu M, Trobridge P, Wang Y, Kanngurn S, Morris SM, Knoblaugh S, Grady WM. 2014. Inactivation of tgf-β signaling and loss of pten cooperate to induce colon cancer in vivo. Oncogene 33:1538–1547.
   PubMed Web of Science ®Google Scholar
• Zhang J, Tsoi H, Li X, Wang H, Gao J, Go MY, Ng SC, et al. 2015. Carbonic anhydrase iv inhibits colon cancer development by inhibiting wnt signaling pathway through targeting wtap-wt1-tbl1 axis. Clin Gastroenterol Hepatol 13:e78al G.
   Web of Science ®Google Scholar
• Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. 2001. Regulation of smad degradation and activity by smurf2, an e3 ubiquitin ligase. Proc Natl Acad Sci 98:974–979.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Wen Z, Darnell J. 1994. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95–98.
   PubMed Web of Science ®Google Scholar
• Zi Z, Feng Z, Chapnick DA, Dahl M, Deng D, Klipp E, Moustakas A, Liu X. 2011. Quantitative analysis of transient and sustained transforming growth factor-β signaling dynamics. Mol Syst Biol 7:492.
   PubMed Web of Science ®Google Scholar
• Zi Z, Klipp E. 2007. Constraint-based modeling and kinetic analysis of the smad dependent TGF-beta signaling pathway. PLoS One 2:e936.
   PubMed Web of Science ®Google Scholar
• Zubay G. 1973. In vitro synthesis of protein in microbial systems. Annu Rev Genet 7:267–287.
   PubMed Web of Science ®Google Scholar